Will NVIDIA Be Knocked Off Its Perch By Quantum?
Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the hopes of speculative tech investors banking on quantum computing to become the next big thing in the ever-advancing race for faster and faster computer processing. Huang, speaking at the Consumer Electronics Show, stated his view that practical quantum computers were still about two decades away, causing a selloff among the stocks of quantum startups. » Read more about: Will NVIDIA Be Knocked Off Its Perch By Quantum? »
Read More
Is United Airlines Set To Crash?
United Airlines has a strange pattern over the next month and a half. In 11 of the past 18 years it has a bizarre bearish pattern where it falls by on average almost 5% over that time frame.
What is it about this time of year when you might anticipate travel bookings are ramping up that this airline has a consistent history of falling by such a large amount?
» Read more about: Is United Airlines Set To Crash? »
Read More
Is Tesla a Buy at $127 Per Share?
Tesla has been widely criticized in recent days with one hedge fund manager even predicting it will go bankrupt. Others have slammed Musk and his leadership for overseeing a larger than expected drop in deliveries. Still others see BYD as serious competition for Tesla with price rivalry threatening margins and the future of the automaker as a whole.
» Read more about: Is Tesla a Buy at $127 Per Share? »
Read More
In 35 Days, The Stock Market Will…
Some forecasters are more famous and some are infamous. Martin Armstrong may well fall more into the latter than the former category. He is the creator of the Economic Confidence Model and has a storied past, including battling the government.
As the narrative goes, Martin built a software that could accurately identify major market trends and turning points,
» Read more about: In 35 Days, The Stock Market Will… »
Read More
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment,
» Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
Philip Morris Surges 75%, Is Its Smoke-Free Pivot a Game Changer?
Shares of cigarette giant Philip Morris (NYSE:PM) have advanced considerably over the last year. The tobacco stock, long looked at mostly for its high dividend yield, has surged by over 75% in the last 12 months and over 20% in the last 30 days alone.
Why has PM stock rallied so far,
» Read more about: Philip Morris Surges 75%, Is Its Smoke-Free Pivot a Game Changer? »
Read MoreThe Spotlight
How Do You Pick a Winning Stock?
Investors will often pour through dozens or even hundreds of stocks looking for the best investment options to add to their portfolios. Before doing this, however, it’s important to first understand what a good stock is.
Let’s take a look at some of the factors that define a good investment to understand what makes a potentially lucrative stock.
» Read more about: How Do You Pick a Winning Stock? »
Read MoreThe Daily
Market volatility has marked Trump's second term — here's how investors have fared
- For all the drama in the stock market of late, investors’ portfolio balances may not look too different from when President Donald Trump entered office in January.
- There have been some unnerving days amid the Trump administration’s tariff policies. The S&P 500 dropped 2% or more on six days between Jan. 20 and June 6,